Kaposi’s sarcoma: The efficacy of a single fraction of 800 cgy

Dermatology

Volumn 195, Issue 2, 1997, Pages 142-144

  Yildiz, F ^a   Ozyar E ^a   Uzal, D ^a   Sahin S ^b   Atahan, I L ^a  

^a Radiation Oncology   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Kaposirsquo s sarcoma; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; EDEMA; FEMALE; FIBROSIS; HUMAN; HYPERPIGMENTATION; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL;

EID: 0030787133     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000245717     Document Type: Article

References (18)

1. Mann SG: Kaposi's sarcoma: Experience with ten cases. Am J Roentgenol Rad Thcr Nucl Med 1974:121:793-800.
2. Nisce LZ, Safai B. Rosillo HP: Once weekly total and subtotal skin electron beam therapy for Kaposi’s sarcoma. Cancer 1981:47: 640-644.
3. Spittle MF: Management of Kaposi's sarcoma. Cancer Topics 1994:9:1-3.
4. Montagnino G. Bencini PL. Tarantino A. Caputo R. Ponticelli C: Clinical features and course of Kaposi's sarcoma in kidney transplant patients: Report of 13 cases. Am J Nephrol 1994:14:121-126.
5. Trattner A. Hodak E. Sandbank M: The appearance of Kaposi Sarcoma during corticosteroid therapy. Cancer 1993:72:1779-1783.
6. DiGiovanna JJ. Safai B: Kaposi's sarcoma-retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am Med J 1981:71:779-783.
7. Hjalgrim H, Melbye M. Lecker S. Frisch M. Thomsen HK. Larsen SO: Epidemiology of Kaposi's sarcoma in Denmark between 1970 and 1992. Cancer 1996:77:1373-1378.
8. Cohen I: Dose, time and volume parameters in radiation therapy of Kaposi's sarcoma. Br J Radiol 1962:35:485-488.
9. Cooper JS: The influence of dose on long term control of classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy. Int J Radiat Oncol Biol Phys 1988:15:1141-1146.
10. Hamilton CR, Cummings BJ, Harwood AR: Radiotherapy of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1986:12:1931-1935.
11. Solan AJ. Greenwald ES. Silvay O: Long term complete remissions of Kaposi's sarcoma with vinblastine therapy. Cancer 1981:47:637-639.
12. Tur E, Brenner S: Treatment of Kaposi's sarcoma. Arch Dermatol 1996:132:327-331.
13. Levy EM. Belkedas JC. Black PH. Lerman RH. Cottrell MC. Kushi LH: Patients with Kaposi’s sarcoma who opt for no treatment. Lancet 1985:vol ii:223.
14. Bakker PJM. Danner SA. Ten Napel CHH. Kroon FP. Sprenger HG. Van Leusen R. Meen-horst PL. Muusers A. Veenhof CHN: Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF). Eur J Cancer 1995:31:188-192.
15. Tavio M. Vaccher E. Antinori A, Ammassari A. Cusini M. Fasan M. Accurso V. Garavelli LP. Repctto L, Tirelli U: Combination chemotherapy with doxorubicin, bleomycin and vindesine for AIDS-related Kaposi's sarcoma. Career 1996:77:2117-2122.
16. Odajnyk C, Muggia FM: Treatment of Kaposi's sarcoma: Overview and analysis by clinical setting. J Clin Oncol 1985:3:1277-1285.
17. Berson AM. Quivey JM. Harris JW. Wara WM: Radiation therapy for AIDS-related Kaposi’s sarcoma. Int J Radiat Oncol Biol Phys 1990:19:569-575.
18. Harwood AR. Osoba D, Hofstadcr S. Goldstein M, Cardella CJ. Holecek MJ, Kunynetz R. Giammarco RA: Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979:67: 759-765.